Connect with us

Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website. .

Investing

AstraZeneca, Smurfit Kappa pull FTSE 100 higher; Darktrace soars on debut

AstraZeneca, Smurfit Kappa pull FTSE 100 higher; Darktrace soars on debut

By Devik Jain

(Reuters) -London’s FTSE 100 edged higher on Friday, boosted by earnings updates from AstraZeneca and Smurfit Kappa, while optimism around a speedy recovery from pandemic-led crash set the blue-chip index for its biggest monthly gain since November 2020.

The FTSE 100 index rose 0.2%, with AstraZeneca gaining 3.7% after it forecast higher sales in the second half of the year.

UK-listed shares of Europe’s largest paper packaging producer Smurfit Kappa Group jumped 3.8% after it posted a 6% increase in first-quarter revenue on strong packaging demand.

The index was further supported by tobacco makers British American Tobacco and Imperial Brands which rose more than 2% each after their peer Swedish Match reported upbeat quarterly profit.

The domestically focused midcap FTSE 250 index advanced 0.2%.

After the U.S. Federal Reserve maintained a status quo on its monetary policy on Wednesday, investors’ focus has now turned towards Bank of England’s meeting on May 6 where it will likely ease its foot off the stimulus pedal and slow bond purchases as Britain’s economy rebounds.

In February, the BoE forecast the economy would grow 5% this year after slumping by almost 10% in 2020.

“The combination of a shallower Q1 contraction, faster exit from lockdown, a more supportive near-term fiscal policy, and a better external backdrop should see the Bank push up its 2021 projections closer to 7% from 5%,” wrote Deutsche Bank economist Sanjay Raja in a note.

“An inevitable growth upgrade would give the monetary policy committee (MPC) enough ammunition to start QE taper.”

Both the UK indexes are on track for their biggest and third consecutive monthly gains so far this year as earnings recovered and businesses reopened on the back of speedy vaccine rollouts and supportive government policies.

Among other stocks, cybersecurity company Darktrace soared 30.9% in its trading debut.

However, Barclays slipped 5.7% to the bottom of the FTSE 100 index even as its first quarter profits more than doubled.

(Reporting by Devik Jain in Bengaluru; editing by Uttaresh.V)

Global Banking & Finance Review

 

Why waste money on news and opinions when you can access them for free?

Take advantage of our newsletter subscription and stay informed on the go!


By submitting this form, you are consenting to receive marketing emails from: Global Banking & Finance Review │ Banking │ Finance │ Technology. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Recent Post